These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 17289881

  • 1. WWOX expression in different histologic types and subtypes of non-small cell lung cancer.
    Donati V, Fontanini G, Dell'Omodarme M, Prati MC, Nuti S, Lucchi M, Mussi A, Fabbri M, Basolo F, Croce CM, Aqeilan RI.
    Clin Cancer Res; 2007 Feb 01; 13(3):884-91. PubMed ID: 17289881
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F, Dosaka-Akita H, Mishina T, Nishi M, Kojima T, Hiroumi H, Ogura S, Shimizu M, Katoh H, Kawakami Y.
    Clin Cancer Res; 2000 Oct 01; 6(10):4073-81. PubMed ID: 11051259
    [Abstract] [Full Text] [Related]

  • 3. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance].
    Hu Z, Xiao T, Lin DM, Guo SP, Zhang ZQ, Di XB, Cheng SJ, Gao YN.
    Zhonghua Zhong Liu Za Zhi; 2007 Aug 01; 29(8):591-5. PubMed ID: 18210878
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH, Wang SF, Yu L, Wang J, Chang H, Yan WL, Zhang J, Fu K.
    Lung Cancer; 2008 Oct 01; 62(1):113-9. PubMed ID: 18550205
    [Abstract] [Full Text] [Related]

  • 5. Expression of MAGE-D4, a novel MAGE family antigen, is correlated with tumor-cell proliferation of non-small cell lung cancer.
    Ito S, Kawano Y, Katakura H, Takenaka K, Adachi M, Sasaki M, Shimizu K, Ikenaka K, Wada H, Tanaka F.
    Lung Cancer; 2006 Jan 01; 51(1):79-88. PubMed ID: 16225959
    [Abstract] [Full Text] [Related]

  • 6. Clinical significance of insulin-like growth factor-binding protein-3 expression in stage I non-small cell lung cancer.
    Chang YS, Kong G, Sun S, Liu D, El-Naggar AK, Khuri FR, Hong WK, Lee HY.
    Clin Cancer Res; 2002 Dec 01; 8(12):3796-802. PubMed ID: 12473592
    [Abstract] [Full Text] [Related]

  • 7. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
    Guler G, Uner A, Guler N, Han SY, Iliopoulos D, Hauck WW, McCue P, Huebner K.
    Cancer; 2004 Apr 15; 100(8):1605-14. PubMed ID: 15073846
    [Abstract] [Full Text] [Related]

  • 8. Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival.
    Zheng S, Chang Y, Hodges KB, Sun Y, Ma X, Xue Y, Williamson SR, Lopez-Beltran A, Montironi R, Cheng L.
    Anticancer Res; 2010 Mar 15; 30(3):713-8. PubMed ID: 20392988
    [Abstract] [Full Text] [Related]

  • 9. [Correlation of P27 expression and localization to phosphorylated AKT in non-small cell lung cancer].
    Miao LJ, Wang J, Li SS, Wu YM, Wu YJ, Wang XC.
    Ai Zheng; 2006 Oct 15; 25(10):1216-20. PubMed ID: 17059763
    [Abstract] [Full Text] [Related]

  • 10. Osteopontin expression and prognostic significance in non-small cell lung cancer.
    Donati V, Boldrini L, Dell'Omodarme M, Prati MC, Faviana P, Camacci T, Lucchi M, Mussi A, Santoro M, Basolo F, Fontanini G.
    Clin Cancer Res; 2005 Sep 15; 11(18):6459-65. PubMed ID: 16166420
    [Abstract] [Full Text] [Related]

  • 11. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A, Yoshino I, Tanaka S, Sugio K, Kameyama T, Yamaguchi M, Maehara Y.
    J Clin Oncol; 2004 Oct 15; 22(20):4165-73. PubMed ID: 15483027
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of insulin receptor substrate-I down-regulation in non-small cell lung cancer.
    Han CH, Cho JY, Moon JT, Kim HJ, Kim SK, Shin DH, Chang J, Ahn CM, Kim SK, Chang YS.
    Oncol Rep; 2006 Dec 15; 16(6):1205-10. PubMed ID: 17089038
    [Abstract] [Full Text] [Related]

  • 13. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
    De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtiö J.
    Lung Cancer; 2009 Mar 15; 63(3):410-7. PubMed ID: 18620780
    [Abstract] [Full Text] [Related]

  • 14. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
    Liao WT, Wang X, Xu LH, Kong QL, Yu CP, Li MZ, Shi L, Zeng MS, Song LB.
    Cancer; 2009 Apr 01; 115(7):1507-17. PubMed ID: 19170237
    [Abstract] [Full Text] [Related]

  • 15. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
    Li L, Mei TH, Zhou XD, Zhang XG.
    Ai Zheng; 2009 Jan 01; 28(1):60-3. PubMed ID: 19448419
    [Abstract] [Full Text] [Related]

  • 16. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL, Liu D, Nakano J, Yokomise H, Ueno M, Kadota K, Wada H.
    Clin Cancer Res; 2007 Dec 01; 13(23):6938-46. PubMed ID: 18056168
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.